Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 18 04:00PM ET
Dollar change
Percentage change
IndexRUT P/E- EPS (ttm)-0.05 Insider Own3.76% Shs Outstand270.03M Perf Week-5.12%
Market Cap1.10B Forward P/E16.60 EPS next Y0.25 Insider Trans-2.03% Shs Float260.24M Perf Month-12.63%
Income-11.94M PEG- EPS next Q0.03 Inst Own49.50% Short Float11.82% Perf Quarter21.79%
Sales198.96M P/S5.55 EPS this Y427.50% Inst Trans8.26% Short Ratio10.30 Perf Half Y-3.55%
Book/sh-0.91 P/B- EPS next Y87.63% ROA-3.10% Short Interest30.76M Perf Year-4.23%
Cash/sh1.09 P/C3.74 EPS next 5Y35.60% ROE- 52W Range3.17 - 5.75 Perf YTD12.09%
Dividend Est.- P/FCF- EPS past 5Y40.58% ROI-11.45% 52W High-29.04% Beta1.34
Dividend TTM- Quick Ratio3.31 Sales past 5Y55.42% Gross Margin68.45% 52W Low28.71% ATR (14)0.21
Dividend Ex-Date- Current Ratio3.59 EPS Y/Y TTM86.73% Oper. Margin5.32% RSI (14)41.15 Volatility3.83% 4.89%
Employees414 Debt/Eq- Sales Y/Y TTM99.42% Profit Margin-6.00% Recom1.40 Target Price7.00
Option/ShortYes / Yes LT Debt/Eq- EPS Q/Q106.31% Payout- Rel Volume0.43 Prev Close4.10
Sales Surprise8.40% EPS Surprise-100.00% Sales Q/Q62.16% EarningsFeb 27 AMC Avg Volume2.98M Price4.08
SMA20-8.57% SMA50-3.71% SMA200-0.38% Trades Volume1,292,105 Change-0.49%
Date Action Analyst Rating Change Price Target Change
Oct-10-23Initiated Wedbush Outperform $10
May-14-21Initiated RBC Capital Mkts Sector Perform $5
Dec-24-19Initiated Oppenheimer Outperform $2.50
Oct-25-19Initiated Cantor Fitzgerald Overweight $3
May-14-19Initiated BTIG Research Buy $3
Mar-04-19Initiated SVB Leerink Outperform $3
Feb-22-19Initiated SVB Leerink Outperform $3
Feb-28-18Downgrade Maxim Group Hold → Sell $1
Nov-01-17Downgrade Maxim Group Buy → Hold
Oct-10-17Initiated H.C. Wainwright Buy $7
Apr-03-24 06:00AM
Mar-26-24 04:05PM
Mar-25-24 11:45AM
Mar-11-24 06:05AM
Mar-05-24 06:05AM
01:01PM Loading…
Mar-04-24 01:01PM
Feb-28-24 09:30AM
Feb-27-24 06:00PM
Feb-20-24 06:00AM
Feb-15-24 06:05AM
12:30PM Loading…
Feb-12-24 12:30PM
Jan-25-24 05:29PM
Jan-02-24 06:05AM
Dec-28-23 06:00AM
Dec-16-23 09:01PM
Nov-08-23 03:27PM
Nov-07-23 09:15PM
Nov-06-23 06:15AM
Nov-01-23 10:01AM
Oct-31-23 04:00PM
Oct-30-23 06:15AM
Sep-07-23 07:08AM
06:00AM Loading…
Sep-05-23 06:00AM
Aug-28-23 06:30PM
Aug-14-23 12:44PM
Aug-08-23 05:16PM
Aug-07-23 06:00PM
Aug-01-23 06:00AM
Jul-31-23 04:00PM
Jul-13-23 07:31AM
Jun-22-23 06:05AM
Jun-11-23 08:05AM
May-28-23 07:49PM
May-24-23 08:30AM
May-23-23 09:50AM
May-10-23 12:02PM
May-09-23 11:30PM
May-02-23 05:00PM
Mar-27-23 04:05PM
Mar-14-23 02:26PM
Mar-07-23 05:00PM
Feb-24-23 01:30AM
Feb-23-23 04:00PM
Feb-22-23 06:05AM
Feb-16-23 05:00PM
Feb-15-23 12:46PM
Feb-10-23 05:00PM
Feb-09-23 08:50AM
Jan-24-23 06:00AM
Jan-23-23 06:05AM
Jan-18-23 08:00AM
Jan-17-23 06:36AM
Jan-05-23 06:00AM
Dec-31-22 07:11AM
Dec-06-22 09:55AM
Nov-30-22 12:29PM
Nov-10-22 06:05AM
Nov-08-22 04:30PM
Nov-01-22 06:00AM
Sep-29-22 11:38AM
Sep-21-22 05:00PM
Sep-19-22 06:00AM
Sep-08-22 01:18PM
Sep-06-22 06:15AM
Sep-01-22 06:00AM
Aug-25-22 09:09AM
Aug-19-22 06:18AM
Aug-16-22 09:03AM
Aug-10-22 07:19AM
Aug-09-22 05:15PM
Aug-02-22 06:00AM
Aug-01-22 07:35PM
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501. The company was founded by Alfred E. Mann on February 14, 1991 and is headquartered in Danbury, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Castagna MichaelChief Executive OfficerDec 15 '23Sale4.0090,482361,9282,148,665Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerDec 14 '23Sale4.00110,000440,0002,239,147Dec 15 09:00 PM
Castagna MichaelChief Executive OfficerNov 01 '23Sale4.2510,00042,5002,349,147Nov 02 09:00 PM
Castagna MichaelChief Executive OfficerOct 02 '23Sale4.6110,00046,1002,359,147Oct 02 09:00 PM
Castagna MichaelChief Executive OfficerSep 01 '23Sale4.6110,00046,1002,436,039Sep 05 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryAug 28 '23Sale4.788,10038,738798,835Aug 28 09:00 PM
Castagna MichaelChief Executive OfficerAug 01 '23Sale4.5710,00045,6862,496,735Aug 01 09:00 PM
Castagna MichaelChief Executive OfficerJul 03 '23Sale4.0710,00040,7012,506,735Jul 05 06:00 AM
Castagna MichaelChief Executive OfficerJun 01 '23Sale4.5310,00045,3022,516,735Jun 02 09:00 PM
Castagna MichaelChief Executive OfficerMay 26 '23Sale4.5075,000337,3352,526,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 25 '23Sale4.5975,000344,4682,601,735May 26 09:00 PM
Castagna MichaelChief Executive OfficerMay 24 '23Sale4.69150,000702,7802,331,735May 24 09:00 PM
Thomson DavidEVP Genl Counsel & SecretaryMay 24 '23Sale4.6895,576447,754735,263May 24 09:00 PM
Binder Steven B.Chief Financial OfficerMay 24 '23Sale4.6747,810223,512838,324May 24 09:00 PM
Castagna MichaelChief Executive OfficerMay 05 '23Sale4.0010,00040,0002,020,128May 05 09:00 PM